Are you Dr. Arnaldez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9000 Rockville Pike Nih Bldg 10crc
10 Center Drive, 1w-3816
Bethesda, MD 20892Phone+1 412-513-5337
Summary
- Dr. Fernanda Arnaldez, MD is a pediatric hematologist/oncologist in Bethesda, Maryland. She is currently licensed to practice medicine in Maryland, New Jersey, and Pennsylvania.
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- UPMC Medical EducationResidency, Pediatrics, 2005 - 2008
- University of Buenos AiresClass of 1999
Certifications & Licensure
- MD State Medical License 2007 - 2026
- NJ State Medical License 2015 - 2017
- PA State Medical License 2005 - 2008
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced so...Diwakar Davar, Benedito A Carneiro, Grace K Dy, Siddharth Sheth, Mitesh J Borad
Journal for Immunotherapy of Cancer. 2024-11-17 - 5 citationsPhase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.Amy S Clark, Fangxin Hong, Richard S Finn, Angela M DeMichele, Edith P Mitchell
Clinical Cancer Research. 2023-04-14 - 65 citationsDual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.Charu Aggarwal, Amy Prawira, Scott Antonia, Osama Rahma, Anthony Tolcher
Journal for Immunotherapy of Cancer. 2022-04-01
Professional Memberships
- Member